ArticleJournal of surgical case reports2025
Lymphoma in the breast: a diagnostic and treatment dilemma.
Article in Journal of surgical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lymphoma involving the breast is an uncommon clinical entity, comprising ˂0.5% of all breast malignancies. Due to its rarity, there is no standardized treatment approach. We describe three patients managed at our centre, each representing a distinct presentation of breast lymphoma: primary breast lymphoma, secondary breast lymphoma, and synchronous disease with concurrent invasive breast carcinoma and lymphoma. Management varied based on histological subtype and disease extent. Therapeutic strategies included combinations of surgery, systemic chemotherapy, and radiotherapy. Each case was discussed in a multidisciplinary tumour board to guide individualized treatment. Breast lymphoma presents diagnostic and therapeutic challenges. Management with multidisciplinary input should be tailored according to lymphoma subtype and patient-specific factors. Further studies are warranted to establish evidence-based treatment protocols.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.